Chen Y, Jiang W, Wu P, Liu Y, Ma Y, Ren H, et al
106 , e4809e4821 (2021)
Several case reports indicate that the concurrent use of GLP-1RAs and dipeptidyl peptidase-IV inhibitors (DPP-4Is) might elevate the risk of developing specific cancers, such as breast, thyroid, and pancreatic cancers [124]
Side effects might include stomach upset, drowsiness, loss or gain of appetite, or irritation of the injection site
You may be a good fit for Wegovy if: Youre living with obesity (BMI 30), or Youre overweight (BMI 27) and have a weight-related health condition, and Youre open to combining the medication with nutrition, physical activity, and behavioural support because Wegovy works best as part of a long-term strategy
Bevilacqua A, et al